Immuno-Safety Technical Committee New Technologies Webinar: Use of NAMs in Immune Safety

The HESI Immuno-Safety Technical (ITC) Committee welcomes Dr. Cara Buchanan from Wellcome Leap, who will present an overview of the immune-competent engineered human models supported by Project Hope.

Speaker Bio: As the HOPE Program Lead at Wellcome Leap, Dr. Buchanan manages a multidisciplinary program that aims to deliver scientific breakthroughs in human health by leveraging engineered human models that recreate tissue function, vascularization and immune competency. Prior to Leap, Dr. Buchanan worked in a start-up where she developed synthetic hydrogel materials for patient-derived organoids in various applications, in close collaboration with academic institutions and biotech partners. Dr. Buchanan trained as a postdoctoral fellow in lymphatic biology at the EPFL in Lausanne, Switzerland and earned her PhD in biomedical engineering from Virginia Tech in Blacksburg, Virginia, USA.

About Wellcome Leap: Wellcome Leap is a wholly owned subsidiary of the Wellcome Trust. Leap builds and executes bold, unconventional programs, funded at scale. Programs that aim to deliver breakthroughs in human health over 5 – 10 years. Such programs require multi-disciplinary, multi-ecosystem teams from universities, companies, and non-profit labs, actively led & orchestrated by a Program Director who adjusts, iterates, and directs teams working together so as to solve problems they cannot solve alone.